Clinical Trial

Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer

Name: Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer — clinical trial record (NCT06850545)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: KuPSMALu

Recruiting

View on ClinicalTrials.gov →

Summary

KuPSMALu-trial is an observational study for patients treated with 177LuPSMA-I\&T in Kuopio University Hospital, Finland. Study focuses on efficacy, safety and biomarker research.

Trial Details

NCT Number	NCT06850545
Lead Sponsor	Kuopio University Hospital Collaborators: University of Eastern Finland
Conditions	Metastatic Prostate Adenocarcinoma, PSMA PET-Positive Castration-Resistant Prostate Cancer
Enrollment	150 participants
Start Date	2020-01-10
Primary Completion	2030-12-31 (estimated)
Study Completion	2035-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-02-27